Confronting head-on the vexed pricing of COVID -19 vaccines

It would cost anything between Rs 13,821 crore to Rs 1,10,568 crore to vaccinate the 20-44 age population

Coronavirus update: Covaxin works against ‘double mutant’, claims ICMR

Covishield to cost Rs 600 a jab at private hospitals

COVID-19 vaccines: Is foreign good for India

The decision to allow foreign vaccines in India may not take plug the current shortage  

Snakebite: Researchers purify commercial Indian antivenoms, find them more potent

Snakebites are classified as a ‘neglected tropical disease’ by the World Health Organization

Covid-19 vaccination drive rolled out in Punjab and Himachal Pradesh, skepticism lingers

Some ASHA workers refused to get the jab on Saturday 

India readies for COVID-19 vaccination but vexed questions on the solution remain

The risks the country needs to prepare for, precautions it needs to take, the logistics required and, above all, the implications of it all for …

Serum Institute’s COVID-19 vaccine up for emergency approval

Civil society organisations urge Indian drug regulator to put vaccine trial data in public domain  

COVID-19 vaccines for all: India’s supply story deconstructed

Vaccination presents a way out of the COVID-19 mess India has landed in; but jabs are in short supply and there’s no clarity …

Vaccine production in South Africa: how an industry in its infancy can be developed

Only if investment is increased, sustained, and backed by political commitment, will the country have sufficient vaccine production capacity

Vaccine Watch: 5 dead in Serum Institute fire; UAE okays Sputnik

PM likely to be vaccinated in March or April, doctor in Shivamogga dies two days after receiving jab and Israel denies vaccine efficacy fears

Norway deaths, social media rumours: Why healthcare workers in Bihar are staying away from vaccines

Nearly 40% healthcare workers scheduled for first 3 days give the jab a miss

WHO approves use of meningitis vaccine on infants

The inexpensive and safe vaccine MenAfriVac can now be used in routine immunisation drives

Bharat Biotech COVID-19 vaccine gets govt panel nod for emergency use: Experts express concern

Recommendation to drug controller for emergency approval to India’s indigenous product against COVID-19

Millions of doses set to expire by September as India’s COVID-19 vaccination drive stagnates

Share of population completely vaccinated grew just 5 percentage points since April

Where are the vaccines for UP’s May 1 COVID-19 vaccination drive

There is extreme shortage of COVID-19 vaccines in India’s largest state and its government is facing problems in procuring them

Centre signs deal with Serum Institute for 11 million COVID-19 vaccine doses: Sources

Talks on with Bharat Biotech; no official statement from government or manufacturers yet

COVID-19 vaccination begins in Bihar; 30,000 health workers to be inoculated today

The vaccination will be staggered over three phases with health and frontline workers and people of 50 to get the shot first

A dose of truth: The real story of India’s COVID-19 vaccination programme

New investigation by Down To Earth stresses on encouraging public sector undertakings to manufacture vaccines — the government seems to agree

Why experts are not happy with India’s COVID-19 vaccine procurement, pricing policy

India only COVID-19 vaccine producer that has shifted burden onto citizens to pay for vaccines by opening private markets for them, experts say

COVID-19 vaccine update: Nearly 35 million jabs administered in India so far

Xi Jinping announces he will start regular visa services for those administered the China-made vaccine; no such vaccine is, however, available in …

Gujarat recipients gung-ho on COVID-19 vaccine

The state will vaccinate about 440,000 healthcare workers and 355,000 frontline workers in the first round

COVID-19 immunity: how long does it last?

In UK’s second wave, previously infected health workers were either completely protected from reinfection or were asymptomatic 

Pfizer withdraws application for Emergency Use Authorisation in India

The company will resubmit application after getting more data

The curious case of Covaxin royalties

ICMR’s contradictions and obfuscation on ownership of the vaccine’s intellectual property is not helping in the fight against COVID-…

COVID-19 Challenge 2021: How does the world overcome vaccine shortage

The pharmaceuticals industry must come together to ensure all adults are vaccinated against the novel coronavirus; …